Overview
About Biognosys
As of 2025, our company has become part of Biognosys Group.
Biognosys Group delivers high-performance, robust solutions across proteomics, metabolomics, and lipidomics — driving innovation at the forefront of multiomics. Building on the combined strengths of PreOmics, Biognosys, and biocrates, Biognosys Group integrates industry-leading consumables, software, instruments, and CRO services to make advanced mass spectrometry workflows seamless, scalable, and accessible to every laboratory.
The Biognosys Group maintains a vendor-neutral strategy, ensuring open and flexible collaboration across the scientific community and broad compatibility of its solutions across the major mass spectrometry platforms.
Designed for agility, Biognosys Group technologies can operate independently or within a unified ecosystem, supported by flexible business models and a strong commitment to partnership. The Biognosys Group is an affiliate of Bruker.
Biognosys Group delivers high-performance, robust solutions across proteomics, metabolomics, and lipidomics — driving innovation at the forefront of multiomics. Building on the combined strengths of PreOmics, Biognosys, and biocrates, Biognosys Group integrates industry-leading consumables, software, instruments, and CRO services to make advanced mass spectrometry workflows seamless, scalable, and accessible to every laboratory.
The Biognosys Group maintains a vendor-neutral strategy, ensuring open and flexible collaboration across the scientific community and broad compatibility of its solutions across the major mass spectrometry platforms.
Designed for agility, Biognosys Group technologies can operate independently or within a unified ecosystem, supported by flexible business models and a strong commitment to partnership. The Biognosys Group is an affiliate of Bruker.
